J.S. de Jong
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
- Oncology top 10%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in ⓘ
- Oncology 6
- Cancer-related Molecular Pathways 4
- Pancreatic and Hepatic Oncology Research 2
- Cancer Cells and Metastasis 2
-
- Cancer, Hypoxia, and Metabolism 2
- Cancer Genomics and Diagnostics 1
- Co-authors
- P. J. van Diest (5 shared papers)Jan P. A. Baak (4 shared papers)Paul van der Valk (3 shared papers)J. P. A. Baak (3 shared papers)P J van Diest (3 shared papers)Rob Michalides (3 shared papers)Reinhard Bos (1 shared paper)Elsken van der Wall (1 shared paper)
- Journals
- Molecular Pathology (3 papers)European Journal of Surgical Oncology (2 papers)Journal of Clinical Pathology (1 paper)Journal of Clinical Oncology (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- NetherlandsUnited States
In The Last Decade
J.S. de Jong
12 papers receiving 829 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 297
- Oncology 390
- Biotechnology 59
- Molecular Biology 443
- Pulmonary and Respiratory Medicine 185
Countries citing papers authored by J.S. de Jong
This map shows the geographic impact of J.S. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.S. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.S. de Jong more than expected).
Fields of papers citing papers by J.S. de Jong
This network shows the impact of papers produced by J.S. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.S. de Jong. The network helps show where J.S. de Jong may publish in the future.
Co-authors
The 25 scholars most cited alongside J.S. de Jong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. | 1997 | 174 |
| 2 | 2005 | 153 | |
| 3 | 1997 | 137 | |
| 4 | Heterogeneity and reproducibility of microvessel counts in breast cancer. | 1995 | 81 |
| 5 | 2010 | 73 | |
| 6 | 2000 | 71 | |
| 7 | 1999 | 66 | |
| 8 | 1996 | 37 | |
| 9 | 1999 | 33 | |
| 10 | 1998 | 14 | |
| 11 | 2010 | 10 | |
| 12 | 2010 | 5 |
About J.S. de Jong
J.S. de Jong is a scholar working on Oncology, Cancer Research, Biotechnology, Radiation and Molecular Biology, having authored 12 papers that have together received 854 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Nanoplatforms for cancer theranostics (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer Cells and Metastasis (2 papers), Cell death mechanisms and regulation (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Cancer Research (297 citations), Oncology (390 citations), Biotechnology (59 citations), Molecular Biology (443 citations) and Pulmonary and Respiratory Medicine (185 citations). J.S. de Jong has collaborated with scholars based in Netherlands and United States. Frequent co-authors include P. J. van Diest, Jan P. A. Baak, Paul van der Valk, J. P. A. Baak, P J van Diest, Rob Michalides, Reinhard Bos, Elsken van der Wall, Petra van der Groep and Paul van der Valk. Their work appears in journals such as Molecular Pathology, European Journal of Surgical Oncology, Journal of Clinical Pathology, Journal of Clinical Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.